FlexiCath
Sterile Catheter Insertion Systems
Health Tech & Life Sciences
Non Active, Nov 2016
Company Overview
Snapshot
Founded in January 2004, FlexiCath operates with 11–50 employees. The company specializes in medical devices for catheterization.
Business overview
FlexiCath develops and markets sterile catheter insertion systems designed to address challenges in midterm (up to 29 days indwelling) IV catheterization. The company's core product, the M/29 Midterm Catheter System, integrates proprietary innovations with established industry technology to provide a safe, easy-to-insert, and touch-free midline catheter for intermediate dwell applications. FlexiCath serves the healthcare industry, specifically targeting providers and the medical equipment sector within the broader Health Tech & Life Sciences market.
Log in to access full profile ›Company Intelligence Q&A
- What is FlexiCath's primary product?
- FlexiCath's primary product is the M/29 Midterm Catheter System, a sterile, touch-free midline catheter designed for intermediate dwell applications of up to 29 days.
- What problem does FlexiCath aim to solve?
- FlexiCath aims to solve issues associated with midterm IV catheterization by providing a safe and easy-to-insert sterile catheter system.
- In which sector does FlexiCath primarily operate?
- FlexiCath primarily operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Medical Treatment & Therapeutics.
- When was FlexiCath founded?
- FlexiCath was founded in January 2004.
- What is the status of FlexiCath?
- FlexiCath has been non-active since November 2016.